BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 7, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

July 26, 2007

View Archived Issues

Recent patents disclose novel strategies for the treatment of respiratory disorders

Read More

Novel agents intended for the treatment of cardiovascular diseases, claimed in recent patents

Read More

Recent patents divulge new options for the treatment of cancer

Read More

Alteon to change name to Synvista Therapeutics

Read More

Expression's phase Ia study of EGEN-001 for ovarian cancer under way

Read More

CTRC begins enrollment for phase II trial of living virus anticancer therapy Reolysin

Read More

Qiagen shareholders vote to acquire Digene

Read More

Akela completes patient enrollment in Fentanyl Taifun phase IIb trial

Read More

Promising preclinical results of Pluristem's PLX cells in limb ischemia

Read More

Brookwood and DelSite extend GelSite codevelopment agreement

Read More

IDM to amend NDA of L-MTP-PE for osteosarcoma; submits MAA to EMEA

Read More

Arius begins preclinical trials of novel CD44-targeting antibody

Read More

BioCryst begins phase II trial of intravenous influenza inhibitor peramivir

Read More

EntreMed commences leukemia clinical trial for MKC-1

Read More

FDA grants fast track designation to Neurochem's drug candidate Alzhemed

Read More

CHMP adopts positive opinion of Pfizer's Ecalta for candidiasis

Read More

Patient recruitment completed for Isotechnika's pivotal phase III psoriasis trial

Read More

Positive results for Advanced Magnetics' fourth phase III trial of ferumoxytol

Read More

Short-term UK-453061 monotherapy effectively decreases viral load in HIV-infected patients

Read More

Schering-Plough Reports Results for Second Quarter of 2007

Read More

rhGH induction-maintenance-reinduction schedule superior to interruption-retreatment for HARS

Read More

Eli Lilly's Forsteo for osteoporosis in men approved by European Commission

Read More

Kowa Pharmaceutical identifies potent and selective PPARalpha agonists for dyslipidemia

Read More

New hepatoselective HMG-CoA reductase inhibitors developed by Pfizer

Read More

Raltegravir + tenofovir/lamivudine exhibits rapid, prolonged antiretroviral activity in HIV patients

Read More

U.S. DTRA and Peregrine enter contract negotiations for hemorrhagic fever treatments

Read More

Targacept initiates phase IIb development of AZD-3480 (TC-1734) for AD

Read More

Novel Spiriva Respimat inhaler for COPD completes European approval process

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 5, 2026.
  • Liver disease

    FB-7033 demonstrates efficacy in MASH management

    BioWorld Science
    17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
  • Illustration of antibody carrying radioactive isotope

    Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC

    BioWorld Science
    At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
  • Bial-Portela discovers new OX1 receptor antagonists

    BioWorld Science
    Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
  • New York University identifies new analogues of mannose-6-phosphate

    BioWorld Science
    New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing